Please assess the completion status of the following clinical trial:

Trial Title: Clinical and Mechanistic Demonstration of a Bioelectric Dressing System for Non-healing Wound Management: A Phase II Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~\> 18 years of age or older, male or female~* Female subject not pregnant - pregnancy excluded by HCG (urine or serum) or by history (tubal ligation, hysterectomy, or menopause).~* Have a non-healing external wound at any location of the body of ≥90 days duration that is (10-50 cm2) at initial screening and does not exceed 3 cm in depth.~* May have a wound requiring Negative Pressure Wound Therapy in conjunction with standard of care wound treatment.~* Subject is able to apply study dressing to his/her wound, or have a reliable and capable caregiver to do it.~* Subjects will have adequate blood flow to the wound as defined by Skin Perfusion Pressure (SPP)47-49 of \>30mmHg recorded over intact epidermis near the open wound margin.~* Subjects with arterial repairs having adequate blood flow to the wound as defined by Skin Perfusion Pressure (SPP) of \>30mmHg recorded over intact epidermis near the open wound margin.~* Absence of clinical signs of infection (such as fever; malodorous wound exudate; increasing wound pain, drainage, erythema, friable granulation tissue and or edema).~* Participant agrees to participate in follow-up evaluations.~* Participant must be able to read and understand informed consent, and signs the informed consent.~Exclusion Criteria:~* Less than 18 years of age.~* Pregnant or lactating woman.~* Have undergone treatment with systemic corticosteroid or immunosuppressive therapy in the past 2 months.~* Currently undergoing dialysis for renal failure.~* Subject has wounds resulting from electrical burn, arterial insufficiency, chemical or radiation insult.~* Subject has wounds with exposed bone, ligament, nerve, artery and/or tendon.~* Active or previous (within 60 days prior to the study screening visit) chemotherapy.~* Active or previous (within 60 days prior to the study screening visit) radiation to the affected wound area to be treated by study device or standard of care.~* Physical or mental disability or geographical concerns (residence not within reasonable travel distance) that would hamper compliance with required study visits.~* The Investigator believes that the subject will be unwilling or unable to comply with study protocol requirements, including application of bioelectric dressings, standard-of-care self-care requirements, and all study-related follow up visit requirements.~* History of infection with Human Immunodeficiency Virus or other immunodeficiency disorders.~* Heterotopic ossification underlying the wound based upon previous imaging or historical information from the subject's chart.~* Severe anemia - Hgb \< 7 g/dl (males) or \< 6.5 (females) or coagulopathy (INR \> 1.7).~* Severe malnutrition (Albumin \< 3.0 gm/dl; \> 10% weight loss in preceding 6 weeks).~* Allergy to silver or zinc.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Bioelectric Dressing (Type: ACTIVE_COMPARATOR): SOC + Bioelectric Dressing
- SOC (Type: NO_INTERVENTION): Standard of Care

Based on this trial design, predict the completion outcome and termination type (if applicable).